Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V4JW
|
|||
Former ID |
DIB012219
|
|||
Drug Name |
SRPIN-340
|
|||
Synonyms |
SRPIN340; 218156-96-8; SRPIN 340; N-(2-(Piperidin-1-yl)-5-(trifluoromethyl)phenyl)isonicotinamide; SRPIN-340; N-[2-(1-Piperidinyl)-5-(trifluoromethyl)phenyl]-4-pyridinecarboxamide; N-[2-(Piperidin-1-yl)-5-(trifluoromethyl)phenyl]pyridine-4-carboxamide; C18H18F3N3O; N-[2-piperidin-1-yl-5-(trifluoromethyl)phenyl]pyridine-4-carboxamide; 4-Pyridinecarboxamide, N-[2-(1-piperidinyl)-5-(trifluoromethyl)phenyl]-; AC1MDY5L; SCHEMBL1110476; SYN5233; EX-A208; AOB1635; MolPort-002-890-093; DWFGGOFPIISJIT-UHFFFAOYSA-N; HMS3653I06
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Choroidal neovascularization [ICD-11: 9B76; ICD-10: H44.2] | Investigative | [1] | |
Company |
University of Bristol
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H18F3N3O
|
|||
Canonical SMILES |
C1CCN(CC1)C2=C(C=C(C=C2)C(F)(F)F)NC(=O)C3=CC=NC=C3
|
|||
InChI |
1S/C18H18F3N3O/c19-18(20,21)14-4-5-16(24-10-2-1-3-11-24)15(12-14)23-17(25)13-6-8-22-9-7-13/h4-9,12H,1-3,10-11H2,(H,23,25)
|
|||
InChIKey |
DWFGGOFPIISJIT-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
3253632, 7707639, 8325343, 12031982, 16329630, 26529623, 40166274, 51694619, 89740360, 92262254, 111450776, 118852799, 124641927, 125512959, 130831288, 137733591, 163644906, 168537556, 170481105, 175426336, 208265341, 210275019, 210280657, 219816897, 223366711, 223384370, 223522966, 223697060, 224101802, 227354085, 246483799, 250221765, 252066102, 252158571, 252160819, 252216337, 252435145, 252449661, 252450245, 252543721, 252554222
|
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.